News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,326 Results
Type
Article (44300)
Company Profile (296)
Press Release (661730)
Section
Business (207290)
Career Advice (2095)
Deals (35844)
Drug Delivery (97)
Drug Development (82536)
Employer Resources (170)
FDA (16366)
Job Trends (15164)
News (351025)
Policy (33348)
Tag
Academia (2682)
Alliances (50246)
Alzheimer's disease (1270)
Approvals (16304)
Artificial intelligence (144)
Bankruptcy (358)
Best Places to Work (11759)
Biotechnology (208)
Breast cancer (186)
Cancer (1341)
Cardiovascular disease (111)
Career advice (1755)
Cell therapy (278)
Clinical research (65747)
Collaboration (452)
Compensation (250)
COVID-19 (2633)
C-suite (110)
Data (1368)
Diabetes (165)
Diagnostics (6371)
Earnings (85489)
Employer resources (148)
Events (112530)
Executive appointments (369)
FDA (17005)
Funding (417)
Gene therapy (200)
GLP-1 (621)
Government (4470)
Healthcare (19171)
Infectious disease (2723)
Inflammatory bowel disease (113)
Interviews (322)
IPO (16475)
Job creations (3794)
Job search strategy (1503)
Layoffs (423)
Legal (8088)
Lung cancer (190)
Manufacturing (198)
Medical device (13353)
Medtech (13358)
Mergers & acquisitions (19503)
Metabolic disorders (446)
Neuroscience (1587)
NextGen Class of 2024 (6674)
Non-profit (4684)
Northern California (1650)
Obesity (260)
Opinion (190)
Patents (114)
People (57607)
Phase I (20430)
Phase II (28890)
Phase III (21582)
Pipeline (507)
Postmarket research (2712)
Preclinical (8835)
Radiopharmaceuticals (242)
Rare diseases (259)
Real estate (6149)
Regulatory (22181)
Research institute (2414)
Resumes & cover letters (354)
Southern California (1432)
Startups (3631)
United States (14900)
Vaccines (573)
Weight loss (184)
Date
Today (41)
Last 7 days (629)
Last 30 days (2410)
Last 365 days (35700)
2024 (34894)
2023 (40583)
2022 (51707)
2021 (56303)
2020 (54928)
2019 (47605)
2018 (35820)
2017 (32826)
2016 (32448)
2015 (38489)
2014 (32384)
2013 (27582)
2012 (29743)
2011 (30395)
2010 (28699)
Location
Africa (756)
Arizona (197)
Asia (38555)
Australia (6365)
California (3710)
Canada (1419)
China (298)
Colorado (170)
Connecticut (171)
Europe (83305)
Florida (514)
Georgia (133)
Illinois (381)
Indiana (220)
Kansas (97)
Maryland (625)
Massachusetts (2913)
Michigan (171)
Minnesota (291)
New Jersey (1074)
New York (1054)
North Carolina (753)
Northern California (1650)
Ohio (145)
Pennsylvania (906)
South America (1165)
Southern California (1432)
Texas (535)
Utah (107)
Washington State (394)
706,326 Results for "american esoteric laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance
Oragenics, Inc. today announced that it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) dated June 18, 2024, notifying the Company that it has accepted the Company’s plan to regain compliance with NYSE American’s continued listing standards.
June 20, 2024
·
2 min read
Formosa Laboratories Completes the Acquisition of Synchem to Expand North American CDMO Footprint
Formosa Laboratories, Inc., a leading API supplier and CDMO headquartered in Taiwan, has successfully completed its acquisition of SynChem, Inc...
June 4, 2024
·
1 min read
Biotech Beach
American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis
Bionano Genomics, Inc., announced that optical genome mapping was included for the first time in the American College of Medical Genetics and Genomics technical laboratory standards documentation for solid tumor analysis.
February 22, 2024
·
6 min read
Press Releases
American Aires Engages ICP Securities Inc. (ICP) for Automated Market Making Services
December 4, 2024
·
6 min read
Press Releases
SystImmune, Inc. Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting
November 26, 2024
·
4 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
CTI Announces Additional College of American Pathologists (CAP) Laboratory Accreditation
CTI Clinical Trials and Consulting, a full-service global research provider, is thrilled to announce that our North American laboratory facility has been granted the prestigious College of American Pathologists
February 22, 2024
·
2 min read
FDA
Association for Diagnostics & Laboratory Medicine (formerly AACC) files an amicus brief backing the American Clinical Laboratory Association’s lawsuit against the FDA
October 7, 2024
·
5 min read
BioCapital
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
Senseonics Holdings, Inc. announced plans to host a business update and analyst event during the American Diabetes Association’s 84th Scientific Sessions in Orlando, FL.
June 13, 2024
·
1 min read
Policy
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Oragenics, Inc., a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced that it received a notice from the NYSE American LLC dated April 18, 2024, notifying the Company that it is no longer in compliance with NYSE American continued listing standards.
April 19, 2024
·
4 min read
1 of 70,633
Next
